SCHEMBL30826796

SCHEMBL30826796

COc1cc(OC2CCNCC2)ccc1C=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.58
ACVR1B P36896 1/20 0.45
TGFBR1 P36897 1/20 0.45
ACVR1 Q04771 1/20 0.45
KCNH2 Q12809 1/20 0.45
ROCK1 Q13464 4/20 0.44
ROCK2 O75116 1/20 0.44
PRKACA P17612 1/20 0.44
PRKCD Q05655 1/20 0.44
PRKG1 Q13976 1/20 0.44
PKN1 Q16512 1/20 0.44
PKN2 Q16513 1/20 0.44
AAK1 Q2M2I8 1/20 0.44
CDC42BPA Q5VT25 1/20 0.44
Q6ZSR9 Q6ZSR9 1/20 0.44
BMP2K Q9NSY1 1/20 0.44
CDC42BPB Q9Y5S2 1/20 0.44
HRH1 P35367 3/20 0.44
IKBKB O14920 1/20 0.43
HRH3 Q9Y5N1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30826663 0.89 TUBB1 (0.45) ALDH1A1ACVR1BTGFBR1ACVR1KCNH2
Hydrochloric Acid SCHEMBL27302123 0.81 TLR9 (0.53) ACVR1BTGFBR1ACVR1KCNH2ROCK1
SCHEMBL16519580 0.80 HRH1 (0.46) ACVR1BTGFBR1ACVR1KCNH2ROCK1
SCHEMBL13362130 0.80 ALDH1A1 (0.54) ALDH1A1ACVR1BTGFBR1ACVR1KCNH2
SCHEMBL12311802 0.80 ACVR1B (0.51) ACVR1BTGFBR1ACVR1KCNH2ROCK1
SCHEMBL2005106 0.79 HRH3 (0.55) ALDH1A1KCNH2HRH3
Hydrochloric Acid SCHEMBL23361975 0.79 HRH1 (0.45) ROCK1ROCK2PRKACAPRKCDPRKG1
Hydrochloric Acid SCHEMBL23086663 0.79 HPGD (0.47) ROCK1ROCK2PRKACAPRKCDPRKG1
SCHEMBL2004982 0.78 HRH3 (0.54) ALDH1A1KCNH2HRH3
SCHEMBL8666130 0.77 ALDH1A1 (0.50) ALDH1A1ACVR1BTGFBR1ACVR1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024064026-A1 AKT1 MODULATORS ALTEROME THERAPEUTICS, INC. (US) 2024-03-28 WO disclosed